Fiera Capital Corp Bluebird Bio, Inc. Transaction History

Fiera Capital Corp

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Aug 22, 2024	BUY	$3.02 - $4.05 $56,857 - $76,249	18,827 New	18,827 $57,000
Q3 2021 Nov 12, 2021	SELL	$11.24 - $21.0 $685 - $1,281	-61 Reduced 0.32%	18,827 $233,000
Q1 2021 May 11, 2021	SELL	$16.59 - $33.89 $6.29 Million - $12.9 Million	-379,306 Reduced 95.26%	18,888 $570,000
Q4 2020 Feb 09, 2021	SELL	$27.5 - $37.92 $364,980 - $503,274	-13,272 Reduced 3.23%	398,194 $17.2 Million
Q3 2020 Nov 12, 2020	SELL	$34.44 - $43.75 $465,249 - $591,018	-13,509 Reduced 3.18%	411,466 $22.2 Million
Q2 2020 Aug 07, 2020	SELL	$27.12 - $45.97 $231,225 - $391,940	-8,526 Reduced 1.97%	424,975 $25.9 Million
Q1 2020 May 08, 2020	BUY	$26.16 - $63.5 $3.02 Million - $7.33 Million	115,444 Added 36.3%	433,501 $19.9 Million
Q4 2019 Feb 06, 2020	SELL	$46.96 - $61.67 $1.87 Million - $2.45 Million	-39,788 Reduced 11.12%	318,057 $27.9 Million
Q3 2019 Nov 12, 2019	BUY	$59.47 - $93.1 $724,106 - $1.13 Million	12,176 Added 3.52%	357,845 $32.9 Million
Q2 2019 Aug 12, 2019	BUY	$75.84 - $105.21 $527,163 - $731,314	6,951 Added 2.05%	345,669 $44 Million
Q1 2019 May 10, 2019	BUY	$64.44 - $104.11 $388,766 - $628,095	6,033 Added 1.81%	338,718 $53.3 Million
Q4 2018 Feb 12, 2019	BUY	$59.1 - $93.26 $19.7 Million - $31 Million	332,685 New	332,685 $33 Million

151

63.4M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $23.1M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Fiera Capital Corp, based on Form 13F filings with the SEC.

Stay updated on Fiera Capital Corp with notifications on news.